16:59 EST Rapt Therapeutics (RAPT) files to sell 176.45M shares of common stock for holders
Meet Your ETF AI Analyst
- Discover how TipRanks' ETF AI Analyst can help you make smarter investment decisions
- Explore ETFs TipRanks' users love and see what insights the ETF AI Analyst reveals about the ones you follow.
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on RAPT:
- RAPT Therapeutics Plans Phase 2b Trials for RPT904
- RAPT Therapeutics Announces Leadership Changes and Realignment
- Rapt Therapeutics appoints Lyons-Williams as chair of board of directors
- Wedbush hikes Apple target to high on Street: Morning Buzz
- Biotech Alert: Searches spiking for these stocks today